Please assess the completion status of the following clinical trial:

Trial Title: Positron Emission Tomography (PET) Imaging of Brain Amyloid Compared to Post-Mortem Levels

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* The subject has a short life expectancy (approximately 1 year or less) as estimated by the Investigator.~* The subject is 70 years of age or older if cognitively normal, or 55 years of age or older if terminal because of dementia.~* The subject's general health is adequate to undergo the study procedures.~Exclusion Criteria:~* The subject has a contraindication for PET.~* The subject has a known or suspected hypersensitivity/allergy to \[18F\]flutemetamol or to any of the excipients.~* The subject is unable to tolerate or cooperate with study procedures.

- Gender: ALL
- Minimum Age: 55 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- [18F] Flutemetamol (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).